Susan LeFrancois

Associate Professor
Susan LeFrancois

Phone 863-874-8528

Location Main Campus

Office BARC-1114

Directory Business Analytics, Data Science

Dr. Susan LeFrancois joined 91ΒιΆΉΣ³»­in July 2013, and has helped to design and build curriculum, participated in outreach activities, and helped to develop industry relationships. Her background extends from work as an educator to industry jobs in the areas of quality assurance and government regulation.

She has taught students science from pre-school to college. From 2008-2012, she was an instructor in industrial and management systems in the College of Engineering at the University of South 91ΒιΆΉΣ³»­ in Tampa. The program was for industry professionals and provided a graduate certificate in medical device and regulatory affairs.

LeFrancois also served as director of quality assurance for FTSI, an industrial sterilizer of medical devices and packaging. She developed and maintained the quality system according to ISO 13485 guidelines. In addition, she was a sterilization industry consultant for the gamma and EtO medical device sterilization industries.

LeFrancois received her doctorate in pharmacology and physiology from the University of 91ΒιΆΉΣ³»­ in Gainesville and her bachelor’s in chemistry from the University of South 91ΒιΆΉΣ³»­. Also, LeFrancois received a graduate certificate in health informatics from the University of South 91ΒιΆΉΣ³»­.

  • Ph.D. in Pharmacology and Physiology, 2004, University of 91ΒιΆΉΣ³»­
  • B.A. in Chemistry, 1999, University of South 91ΒιΆΉΣ³»­
  • Graduate Certificate in Health Informatics, 2016, University of South 91ΒιΆΉΣ³»­
  • Population health
  • Social determinants of health
  • Healthcare in the U.S.
  • Nicotinic acetylcholine receptors
  • DMXBA/ GTS-21
  • HIMSS (member)
  • Lakeland Volunteers in Medicine (Board Member)
  • Svetoslav H.Slavov, Maksim Radzvilovits, Susan LeFrancois,Iva B.Stoyanova-Slavova, Ferenc Soti, William R.Kem, Alan R.Katritzky. (2010). β€œanabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.” European Journal of Medicinal Chemistry, 45, 2433-2446.
  • William R Kem, Vladimir M Mahnir, Laszlo Prokai, Roger L Papke, Xuefang Cao, Susan LeFrancois, Kristin Wildeboer, Katalin Prokai-Tatrai, Julia Porter-Papke, Ferenc Soti. (2004). β€œ.” Molecular pharmacology, 65, 56-67.
  • William Kem, Ferenc Soti, Kristin Wildeboer, Susan LeFrancois, Kelly MacDougall, Dong-Qing Wei, Kuo-Chen Chou, Hugo R Arias. (2006) β€œThe nemertine toxin anabaseine and its derivative DMXBA (GTS-21): Chemical and pharmacological properties.” Marine Drugs, 4, 255-273.
  • William R. Kem, Kristin Wildeboer, Susan LeFrancois, Ma’an Raja, William Marszalec, Jean-Claude Braekman. (2004) β€œ,” Cellular and Molecular Neurobiology, 24, 535-551.
  • SE LeFrancois. A structure activity investigation of benzylidene anabaseine interactions with the alpha7 nicotinic acetylcholine receptor. Dissertation, 2004.

*External, third-party sites not maintained by 91ΒιΆΉΣ³»­ Polytechnic University